78 Brown E, Wilding JPH, Barber TM, Alam U, Cuthbertson DJ
If the established threshold was reached within 2 seconds, the red circle was replaced by a green circle
For weight management specifically, the FDA has approved semaglutide 2.4 mg weekly (Wegovy), liraglutide 3.0 mg daily (Saxenda), and tirzepatide (Zepbound) for adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Consequently, the observed differences between both feeding groups in non-mitochondrial respiration may not be exclusively explained by this metabolic pathway
Remind your clients that benefits arent just a cost line
In brief, over perhaps a two year period my health went totally to hell